We are live on ! Find out more
1CM

1492 Capital Management Portfolio holdings

AUM $263M
1-Year Est. Return 61.9%
This Fund
S&P 500
This Quarter Est. Return
+22.88%
1 Year Est. Return
+61.9%
3 Year Est. Return
+187.15%
5 Year Est. Return
+242.53%
10 Year Est. Return
+2,731.07%
AUM
$217M
AUM Growth
+$31.3M
Cap. Flow
+$736K
Cap. Flow %
0.34%
Top 10 Hldgs %
30.54%
Holding
129
New
17
Increased
30
Reduced
44
Closed
16

Top Buys

Rank Stock Value
1
TNDM icon
Tandem Diabetes Care
TNDM
+$3.29M
2
MTH icon
Meritage Homes
MTH
+$2.07M
3
JEF icon
Jefferies Financial Group
JEF
+$1.9M
4
DEFT
Defi Technologies
DEFT
+$1.58M
5
AMKR icon
Amkor Technology
AMKR
+$1.49M

Top Sells

Rank Stock Value
1
EHC icon
Encompass Health
EHC
+$5.89M
2
STRL icon
Sterling Infrastructure
STRL
+$4.77M
3
VBTX
Veritex Holdings
VBTX
+$3.82M
4
ATI icon
ATI
ATI
+$2.14M
5
DCGO icon
DocGo
DCGO
+$1.75M

Sector Composition

Rank Sector Weight
1 Technology 27.38%
2 Industrials 17.54%
3 Healthcare 15.44%
4 Financials 10.6%
5 Consumer Discretionary 10.56%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
THG icon
126
Hanover Insurance
THG
$7.98B
– –
-6,518
Closed -$1.13M
VRTX icon
127
Vertex Pharmaceuticals
VRTX
$126B
– –
-496
Closed -$240K
ASTH icon
128
Astrana Health
ASTH
$1.77B
– –
-26,860
Closed -$833K
SYRS
129
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
– –
-39,244
Closed -$1.18K
2 3 4 5
6

Similar funds

KA
Kerrisdale Advisers Miami, Florida $263M AUM 40.01% 1-Year Est. Return
DEA
DoubleLine ETF Adviser Tampa, Florida $263M AUM 8.83% 1-Year Est. Return
EAN
Excelsior Advisor Network Denver, Colorado $263M AUM
SC
Sagil Capital London, United Kingdom $263M AUM 88.6% 1-Year Est. Return
L
Laurore Hong Kong $263M AUM
LB
Legacy Bridge West Des Moines, Iowa $262M AUM 56.69% 1-Year Est. Return
ACM
Ananym Capital Management New York $262M AUM 22.94% 1-Year Est. Return
TSW
Three Seasons Wealth Salt Lake City, Utah $262M AUM 45.03% 1-Year Est. Return

1492 Capital Management's Q2 2025 Portfolio in Review

As of Q2 2025, 1492 Capital Management held 129 positions worth $217M, up 17% from $186M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

1492 Capital Management's Q2 2025 filing shows 17 new, 30 increased, 44 reduced and 16 closed positions. Its largest new stake was Defi Technologies: 472,314 shares worth $1.38M. The largest sale was Encompass Health, an estimated $5.89M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Industrials and Healthcare.

  • 1492 Capital Management's largest Q2 2025 buy was Defi Technologies: 472,314 shares worth $1.38M.
  • 1492 Capital Management added most to Tandem Diabetes Care in Q2 2025, an estimated $3.29M increase.
  • 1492 Capital Management's biggest Q2 2025 reduction was Sterling Infrastructure, cutting an estimated $4.77M.
  • 1492 Capital Management fully exited Encompass Health in Q2 2025, selling an estimated $5.89M.
  • 1492 Capital Management's ten largest holdings make up 31% of its $217M portfolio in Q2 2025.
  • 1492 Capital Management opened 17 new positions and closed 16 in Q2 2025.
  • 1492 Capital Management's portfolio value rose 17% quarter-over-quarter to $217M.

Based on 1492 Capital Management's 13F filing for Q2 2025, filed 13 Aug 2025.